Correlation Between Mineralys Therapeutics, and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Mineralys Therapeutics, and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Sonnet Biotherapeutics.
Diversification Opportunities for Mineralys Therapeutics, and Sonnet Biotherapeutics
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Sonnet is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Sonnet Biotherapeutics
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 1.23 times more return on investment than Sonnet Biotherapeutics. However, Mineralys Therapeutics, is 1.23 times more volatile than Sonnet Biotherapeutics Holdings. It trades about -0.07 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.52 per unit of risk. If you would invest 1,389 in Mineralys Therapeutics, Common on August 27, 2024 and sell it today you would lose (140.00) from holding Mineralys Therapeutics, Common or give up 10.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Sonnet Biotherapeutics Holding
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Sonnet Biotherapeutics |
Mineralys Therapeutics, and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Sonnet Biotherapeutics
The main advantage of trading using opposite Mineralys Therapeutics, and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| Sonnet Biotherapeutics vs. Eliem Therapeutics | Sonnet Biotherapeutics vs. HCW Biologics | Sonnet Biotherapeutics vs. Scpharmaceuticals | Sonnet Biotherapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |